Monitoring and Evaluation of COVID-19 Screening, Testing, and Treatment

Overview

In 2021, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) was awarded the Catalyzing COVID-19 Action (CCA) project, an initiative funded by FIND and UNITAID. The goal of CCA project is to accelerate end-to-end access to novel solutions in the COVID-19 pandemic response by adapting testing, isolation, care, and treatment approaches to meet the needs of three countries – Cameroon, Kenya, and Zimbabwe. The CCA project aims to propel innovation and access to these tailored solutions through five work areas: evidence generation, catalytic implementation, advocacy, demand generation, and transition to national programs for sustainable impact.

Through catalytic implementation, the CCA project aimed to increase access and use of screening, testing, and treatment for COVID-19. This was accomplished through decentralizing and integrating these services into existing entry points, such as the HIV, TB, and MNCH clinics in CCA-supported sites, as well as generating robust data to monitor these services for decision-making and midcourse correction.

At the beginning of the CCA project in 2021, however, all three countries where CCA was to be implemented were at the beginning stages of developing national systems and tools for tracking COVID-19. There was very little global guidance on how to monitor COVID-19 at health facilities. As a result, as demonstrated in Figure 2, the team created an original indicator framework with custom indicators that monitored patient outcomes across the COVID-19 continuum of care.